P/E ratio for Mouwasat Medical Services Company (4002.SR)
P/E ratio as of May 2024 (TTM): 43.0
According to Mouwasat Medical Services Company's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 42.9802. At the end of 2022 the company had a P/E ratio of 69.9.
P/E ratio history for Mouwasat Medical Services Company from 2012 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 69.9 | 16.23% |
| 2021 | 60.1 | 15.05% |
| 2020 | 52.3 | 24.74% |
| 2019 | 41.9 | -6.3% |
| 2018 | 44.7 | -0.45% |
| 2017 | 44.9 | -23.05% |
| 2016 | 58.4 | 0.18% |
| 2015 | 58.3 | 12.8% |
| 2014 | 51.7 | 12.6% |
| 2013 | 45.9 | 48.97% |
| 2012 | 30.8 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.